60 articles related to "compulsory licence"
U.S. Penalises India for Promoting Access to Medicines Strategies by Placing it on Trade "Watch List"
The U.S. Trade Representative's decision to place India on its annual trade "Watch List" is a bully tactic being used to punish the country for taking steps to ensure access to affordable,...
Statements, Speeches, Letters – Last updated 02 May 2013
A liver cancer treatment is off-limits in the NHS due to its unjustifiably high price tag, but in India the same treatment is available for less than £100 a month. In this week's Scrubbing...
Op-eds & Articles – Last updated 28 March 2013
New Delhi/Geneva, 4 March 2013 – The verdict into German pharmaceutical company Bayer’s appeal against the grant of a compulsory licence has been issued by India’s Intellectual Property...
Statements, Speeches, Letters – Last updated 04 March 2013
Final hearings begin in Bayer's appeal against Indian move to allow production of more affordable cancer drug
Further compulsory licences on high-price patented medicines expected 18 January 2013 - This week, final hearings began in Chennai, India, in the appeal that German pharmaceutical company Bayer...
Statements, Speeches, Letters – Last updated 18 January 2013
On 3 September, the Government of Indonesia issued a 'government use' decree - a type of compulsory licence that lifts a patent restriction on generic production - on seven drugs used to treat...
Statements, Speeches, Letters – Last updated 12 October 2012
MSF statement at WIPO General Assemblies on Agenda item 28(i) Standing Committee on the Law of Patents
Thanks Mr. Chairman. I am speaking on behalf of Médecins Sans Frontières International. MSF is an independent medical humanitarian organisation that works in over 65 countries around...
Statements, Speeches, Letters – Last updated 06 October 2012
17 September 2012 - India's Intellectual Property Appellate Board (IPAB) has dismissed Bayer’s request for a stay order against the compulsory licence granted by the Patent Controller...
Statements, Speeches, Letters – Last updated 17 September 2012
German company appeals against life-saving compulsory licence decision in India Geneva/New Delhi, 3 September, 2012 – German pharmaceutical company Bayer today heads to India’s Intellectual...
Press Release – Last updated 26 September 2012
Médecins Sans Frontières (MSF) has learnt that India's Intellectual Property Appellate Board (IPAB) in Chennai has postponed hearing the appeal by German pharmaceutical company Bayer...
Statements, Speeches, Letters – Last updated 21 August 2012
Washington, DC, 25 July 2012 —Middle-income countries are increasingly taking measures to overcome the patents that price drugs out of reach, according to a new report released today from...
Press Release – Last updated 26 July 2012